IL105573A - Production of 2',3'-dideoxy-2', 2'-didehydronucleosides - Google Patents

Production of 2',3'-dideoxy-2', 2'-didehydronucleosides

Info

Publication number
IL105573A
IL105573A IL10557389A IL10557389A IL105573A IL 105573 A IL105573 A IL 105573A IL 10557389 A IL10557389 A IL 10557389A IL 10557389 A IL10557389 A IL 10557389A IL 105573 A IL105573 A IL 105573A
Authority
IL
Israel
Prior art keywords
dideoxy
represented
formula
amino
groups
Prior art date
Application number
IL10557389A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL105573A publication Critical patent/IL105573A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10557389A 1988-03-24 1989-03-21 Production of 2',3'-dideoxy-2', 2'-didehydronucleosides IL105573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/173,473 US4904770A (en) 1988-03-24 1988-03-24 Production of 2',3'-dideoxy-2',3'-didehydronucleosides

Publications (1)

Publication Number Publication Date
IL105573A true IL105573A (en) 1994-04-12

Family

ID=22632190

Family Applications (2)

Application Number Title Priority Date Filing Date
IL8969389A IL89693A (en) 1988-03-24 1989-03-21 Production of 2', 3'-dideoxy-2', 3'-didehydronucleosides
IL10557389A IL105573A (en) 1988-03-24 1989-03-21 Production of 2',3'-dideoxy-2', 2'-didehydronucleosides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL8969389A IL89693A (en) 1988-03-24 1989-03-21 Production of 2', 3'-dideoxy-2', 3'-didehydronucleosides

Country Status (14)

Country Link
US (1) US4904770A (fi)
EP (1) EP0334368A3 (fi)
JP (1) JPH02149595A (fi)
KR (2) KR0140889B1 (fi)
AU (1) AU622439B2 (fi)
CA (1) CA1339448C (fi)
DK (1) DK146489A (fi)
EG (1) EG18661A (fi)
FI (1) FI93111C (fi)
IL (2) IL89693A (fi)
NO (1) NO171367C (fi)
NZ (1) NZ228390A (fi)
PT (1) PT90099B (fi)
ZA (1) ZA892166B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455339A (en) * 1986-05-01 1995-10-03 University Of Georgia Research Foundation, Inc. Method for the preparation of 2',3'-dideoxy and 2',3'-dideoxydide-hydro nucleosides
US5384396A (en) * 1988-02-23 1995-01-24 The University Of Georgia Research Foundation, Inc. Process for the deoxygenation of nucleosides
JPH02152976A (ja) * 1988-05-06 1990-06-12 Bristol Myers Co ２´，３´―ジデヒドロ―２´，３´―ジデオキシヌクレオシドのプロドラッグ
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
US5200514A (en) * 1990-01-19 1993-04-06 University Of Georgia Research Foundation, Inc. Synthesis of 2'-deoxypyrimidine nucleosides
EP0493602A4 (en) * 1990-07-27 1993-01-20 Yuki Gosei Kogyo Co., Ltd. Process for producing 2',3'-dideoxy-2',3'-didehydronucleoside
US5166327A (en) * 1990-07-31 1992-11-24 Yuki Gosei Kogyo Co., Ltd. Process for producing 3'-deoxy-3-'-fluorothymidine
JP3042073B2 (ja) * 1991-06-19 2000-05-15 味の素株式会社 ヌクレオシド誘導体とその製造方法
DE550714T1 (de) * 1991-06-21 1995-06-14 Acic Canada Inc Antiviralverbindungen und Ihrer Verfahren zur Herstellung.
FR2688003B1 (fr) * 1992-02-28 1995-06-30 Univ Limoges Derives de nucleosides, leur preparation et leurs applications biologiques.
US5506349A (en) * 1992-05-13 1996-04-09 Ribozyme Pharmaceuticals, Inc. Chemical synthesis of 2', 3'-dideoxycytidine
US5539099A (en) * 1993-11-15 1996-07-23 Bristol-Myers Squibb Company Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
US5608049A (en) * 1995-03-10 1997-03-04 Bristol-Myers Squibb Company Preparation of d4T from 5-methyluridine
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
US6635753B1 (en) 1998-09-30 2003-10-21 Brantford Chemicals Inc. Process for the preparation of substantially pure stavudine and related intermediates useful in the preparation thereof
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
IT1318463B1 (it) * 2000-04-12 2003-08-25 Archimica S P A Ora Clariant L Procedimento per la preparazione di 5'-acetilstavudina.
CN1505635A (zh) 2001-03-01 2004-06-16 2′,3′-二脱氧-2＇,3＇-二脱氢核苷的合成方法
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US20050171126A1 (en) * 2003-12-26 2005-08-04 Ajinomoto Co., Inc. Process for the production of purine nucleoside compounds
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US20090148407A1 (en) 2005-07-25 2009-06-11 Intermune, Inc. Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
CN101029068B (zh) * 2007-04-09 2010-06-23 陆咏 一种2',3'-二脱氢-3'-脱氧胸苷的合成方法
LT2750768T (lt) 2011-08-30 2019-02-11 Astex Pharmaceuticals, Inc. Decitabino darinio kompozicijos
US20160060252A1 (en) * 2013-04-16 2016-03-03 Bristol-Myers Squibb Company 5-methyluridine method for producing festinavir
AU2016287585B2 (en) 2015-07-02 2020-12-17 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
MX2020001233A (es) 2017-08-03 2020-07-20 Otsuka Pharma Co Ltd Compuesto farmaceutico y metodos de purificacion del mismo.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322747A (en) * 1965-04-01 1967-05-30 Merck & Co Inc Thionocarbonate nucleosides
US3539550A (en) * 1967-01-23 1970-11-10 Syntex Corp Process for the preparation of 2'-halo-2'-deoxy pyrimidine nucleosides
US3792040A (en) * 1970-03-19 1974-02-12 Syntex Corp Acyl derivatives of o2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosines and methods of preparing

Also Published As

Publication number Publication date
FI891338A0 (fi) 1989-03-21
CA1339448C (en) 1997-09-09
FI93111C (fi) 1995-02-27
IL89693A0 (en) 1989-09-28
DK146489D0 (da) 1989-03-22
FI93111B (fi) 1994-11-15
EP0334368A2 (en) 1989-09-27
IL89693A (en) 1994-08-26
NO171367B (no) 1992-11-23
NO891208D0 (no) 1989-03-20
KR0140889B1 (en) 1998-06-15
EG18661A (en) 1993-10-30
NO891208L (no) 1989-09-25
FI891338A (fi) 1989-09-25
AU3167389A (en) 1989-09-28
EP0334368A3 (en) 1991-12-27
KR0142109B1 (en) 1998-07-01
ZA892166B (en) 1992-02-26
NZ228390A (en) 1991-12-23
PT90099A (pt) 1989-11-10
AU622439B2 (en) 1992-04-09
KR890014528A (ko) 1989-10-24
US4904770A (en) 1990-02-27
DK146489A (da) 1989-09-25
JPH02149595A (ja) 1990-06-08
NO171367C (no) 1993-03-03
PT90099B (pt) 1994-07-29

Similar Documents

Publication Publication Date Title
IL105573A (en) Production of 2',3'-dideoxy-2', 2'-didehydronucleosides
Herdewijn et al. 3'-Substituted 2', 3'-dideoxynucleoside analogs as potential anti-HIV (HTLV-III/LAV) agents
Mansuri et al. 1-(2, 3-Dideoxy-. beta.-D-glycero-pent-2-enofuranosyl) thymine. A highly potent and selective anti-HIV agent
US6090932A (en) Method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
Fleet et al. Methyl 5-0-tert-butyldiphenylsilyl-2-deoxy-α β-d-threo-pentofuranoside as a divergent intermediate for the synthesis of 3'-substituted-2', 3'-dideoxynucleosides: synthesis of 3'-azido-3'-deoxythymidine, 3'-deoxy-3'-fluorothymidine and 3'-cyano-3'-deoxythymidine.
Tanaka et al. Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogs of 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT)
IE62914B1 (en) Pyrimidine derivatives
JP2699049B2 (ja) ２′，３′−ジデオキシ−２′−フルオロ−ヌクレオシド
US5130421A (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
JPH05508152A (ja) 抗ウイルス剤としての２’，３’―ジデオキシ―４’―チオリボヌクレオシド
Maillard et al. Synthesis of 3′-substituted-2′, 3′-dideoxynucleoside analogs as potential anti-aids drugs
WO1994014831A1 (en) Dihydropyrimidine nucleosides with antiviral properties
EP0340778A2 (en) Prodrugs of 2',3'- Didehydro-2',3'-Dideoxynucleosides
CA1339861C (en) 3roduction of 2',3' -dideoxy -2',3'-didehydronucleosides
US5212294A (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
IL105571A (en) Production of 2'-3'-dideoxy-2'3'- didehydronucleosides
NZ238678A (en) Process for preparing 2',3'-dideoxy-2',3'-didehydronucleosides
KR0142110B1 (ko) 2', 3'-디데옥시-2', 3'-디데히드로누클레오시드의 제조방법
US5506215A (en) 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
NZ229000A (en) 2',3'-didehydro-2',3'-dideoxynucleosides, process for their preparation and pharmaceutical compositions thereof
Yamaguchi et al. Synthetic Nucleosides and Nucleotides. XXX. 1 Synthesis and Antiviral Activity of 3′-Azido, 2′, 3′-Unsaturated and 2′, 3′-Dideoxy Derivatives of E-5-Styryl-2′-Deoxyuridine on Human Immunodeficiency Virus
NO171314B (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider
NO171315B (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider
NO171316B (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider r
KR920004982B1 (ko) 2',3'-디데옥시-2',3'-디데히드로-2'-플루오로뉴클레오사이드류

Legal Events

Date Code Title Description
RH Patent void